Harvard Bioscience Inc. (HBIO)
HBIO trades on Nasdaq in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$8.27
+0.36% on the day
Market cap
$37.6M
Nano cap
Revenue · 2025
$86.5M
-8.1% on 2024
Net income · 2025
-$56.7M
-65.5% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | HBIO on Nasdaq |
| Sector | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments |
| Country | United States |
| IPO year | 2000 |
| SEC CIK | 0001123494 |
| SEC industry code | Laboratory Analytical Instruments |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $86.5M |
| Net income | -$56.7M |
| Operating income | -$48.6M |
| Net margin | -65.5% |
| Operating margin | -56.1% |
| Revenue growth | -8.1% |
| Cash | $8.6M |
| Total assets | $80.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.4× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B3 | 424B3 | 2026-02-09 |
| Latest annual report FORM 10-K | 10-K | 2026-03-13 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-08-11 |
| Latest current report FORM 8-K | 8-K | 2026-08-11 |
| Latest proxy FORM DEFA14A | DEFA14A | 2026-04-21 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Biotechnology: Laboratory Analytical Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PRPO | Precipio Inc. | $22.59 | 0.00% | $40.4M |
| CIRC | Circle8 Group Inc. | $0.3611 | -19.38% | $42.4M |
| RPID | Rapid Micro Biosystems Inc. | $0.8738 | -0.57% | $43.8M |
| BNGO | Bionano Genomics Inc. | $1.36 | +1.11% | $16.0M |
| ASTC | Astrotech Corporation (DE) | $6.06 | -1.94% | $12.2M |
| SEER | Seer Inc. | $2.11 | -1.86% | $116.8M |
| QTRX | Quanterix Corporation | $3.15 | -0.32% | $149.0M |
| LAB | Standard BioTools Inc. | $0.6589 | +0.17% | $260.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier